How to successfully implement home healthcare with direct-to-patient IMP delivery

Stuart Redding, Vice President of Global Business Development at MRN, and Dave Spillet, Key Account Director at World Courier, share their experiences of setting up and implementing the home care model, taking into account varying international regulation, the criticality of patient confidentiality and risk mitigation. They explore how practical knowledge and experience are the keys to successfully improving patient experience and moving medicine forwards.

Key Learning Objectives

  • Understand the practical implications affecting patient recruitment and retention
  • Hear about the value of a one stop shop and how quality and compliance are improved and competitive advantage can be gained
  • Understand how the practicalities of set up and implementation can make or break a study
  • Uncover the impact a patient-centric approach can have on trials and patients


Stuart Redding

Vice President of Global Business Development

The Medical Research Network

Stuart has over 20 years’ experience in the pharmaceutical industry, successfully delivering clinical trials, with a focus on patient recruitment & retention. Stuart has worked across many disciplines, including data management, clinical operations, project management,feasibility, budget & proposal development, business development & marketing. Stuart worked with both Sponsors (American Cyanamid, Novo Nordisk) & CROs (MDS Harris, Chiltern), before joining MRN in 2006 as one of the founders & Head of Project Management. Stuart currently has responsibility for global business development & marketing, with a focus on educating customers in how to utilise home healthcare for successful clinical trial completion.

David Spillett

Key Account Director

World Courier

David is a pharmaceutical services professional with over 15 years' experience in the provision of GXP compliant services. He is considered a subject matter expert in the context of Clinical Trial Supplies and is one of the few GMP/GDP specialists whose experience includes the administration of investigational products in a clinical setting. David is currently Key Account Director at World Courier where he is often called upon to assist in solving the supply chain challenges associated with novel therapies. He has previously worked as a Clinical Supplies Lead for Penn Pharma where he managed pharmaceutical development and supply chain projects for a variety of small, medium and large pharmaceutical companies. David holds a post graduate diploma in clinical research gained whilst working as a Research Physiologist at Simbec Research Ltd.

This presentation is the third webinar of the series. The first two can be viewed via the links below:

Patient Centric Approach
Optimizing Home Healthcare in Clinical Trials Through Strategic Partnership